54
Views
0
CrossRef citations to date
0
Altmetric
FIBROMYALGIA SYNDROME

Neuroimaging in Fibromyalgia Syndrome

, MD
Pages 387-392 | Published online: 25 Oct 2010

REFERENCES

  • Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, Stewart KE, Alarcón GS, Mountz JD: Fibromyalgia in women: Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38: 926–938, 1995.
  • Bradley LA, Sotolongo A, Alberts KR, Alarcon GS, Mountz JM, Liu HG, Kersh BC, Domino ML, De Waal D, Weigent DA, Blalock JE: Abnormal regional cerebral blood flow in the caudate nucleus among fibromyalgia patients and non-patients is associated with insidious symptom onset. J Musculoske Pain 7: 285–292, 1999.
  • Kwiatek R, Barnden L, Tedman R, Jarrett R, Chew J, Rowe C, Pile K: Regional cerebral blood flow in fibromyalgia: Single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 43: 2823–2833, 2000.
  • Guedj E, Taieb D, Cammilleri S, Lussato D, de Laforte C, Niboyet J, Mundler O: 99mTc-ECD brain perfusion SPECT in hyperalgesic fibromyalgia. Eur J Nucl Med Mol Imaging 34: 130–134, 2007.
  • Guedj E, Cammilleri S, Colavolpe C, Taieb D, de Laforte C, Niboyet J, Mundler O: Predictive value of brain perfusion SPECT for ketamine response in hyperalgesic fibromyalgia. Eur J Nucl Med Mol Imaging 34: 1274–1279, 2007.
  • Guedj E, Cammilleri S, Colavolpe C, de Laforte C, Niboyet J, Mundler O: Follow-up of pain processing recovery after ketamine in hyperalgesic fibromyalgia patients using brain perfusion ECD-SPECT. Eur J Nucl Med Mol Imaging 34: 2115–2119, 2007.
  • Guedj E, Cammilleri S, Niboyet J, Dupont P, Vidal E, Dropinski JP, Mundler O: Clinical correlate of brain SPECT perfusion abnormalities in fibromyalgia. J Nucl Med 49: 1798–1803, 2008.
  • Adigüzel O, Kaptanoglu E, Turgut B, Nacitarhan V: The possible effect of clinical recovery on regional cerebral blood flow deficits in fibromyalgia: A prospective study with semiquantitative SPECT. South Med J 97: 651–655, 2004.
  • Usui C, Hatta K, Doi N, Nakanishi A, Nakamura H, Nishioka K, Arai H: Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin. Arthritis Res Ther 12: R64, 2010.
  • Yunus MB, Young CS, Saeed SA, Mountz JM, Aldag JC: Positron emission tomography in patients with fibromyalgia syndrome and healthy controls. Arthritis Rheum 51: 513–518, 2004.
  • Walitt B, Roebuck-Spencer T, Esposito G, Atkins F, Bleiberg J, Foster G, Weinstein A: The effects of multidisciplinary therapy on positron emission tomography of the brain in fibromyalgia: A pilot study. Rheumatol Int 27: 1019–1024, 2007.
  • Wood PB, Holman AJ: An elephant among us: The role of dopamine in the pathophysiology of fibromyalgia. J Rheumatol 36: 221–224, 2009.
  • Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA, Bushnell MC, Chizh BA: Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25: 3576–3582, 2007.
  • Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK: Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 27: 10000–10006, 2007.
  • Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, Bushnell MC: Accelerated brain gray matter loss in fibromyalgia patients: Premature aging of the brain? J Neurosci 27: 4004–4007, 2007.
  • Schmidt-Wilcke T: Variations in brain volume and regional morphology associated with chronic pain. Curr Rheumatol Rep 10: 467–474, 2008.
  • Wood PB, Glabus MF, Simpson R, Patterson JC 2nd: Changes in gray matter density in fibromyalgia: Correlation with dopamine metabolism. J Pain 10: 609–618, 2009.
  • Lutz J, Jäger L, de Quervain D, Krauseneck T, Padberg F, Wichnalek M, Beyer A, Stahl R, Zirngibl B, Morhard D, Reiser M, Schelling G: White and gray matter abnormalities in the brain of patients with fibromyalgia: A diffusion-tensor and volumetric imaging study. Arthritis Rheum 58: 3960–3969, 2008.
  • Burgmer M, Gaubitz M, Konrad C, Wrenger M, Hilgart S, Heuft G, Pfleiderer B: Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med 71: 566–573, 2009.
  • Schmidt-Wilcke T, Luerding R, Weigand T, Jürgens T, Schuierer G, Leinisch E, Bogdahn U: Striatal grey matter increase in patients suffering from fibromyalgia—A voxel-based morphometry study. Pain 132 (Suppl 1): S109–S116. 2007.
  • Sundgren PC, Petrou M, Harris RE, Fan X, Foerster B, Mehrotra N, Sen A, Clauw DJ, Welsh RC: Diffusion-weighted and diffusion tensor imaging in fibromyalgia patients: A prospective study of whole brain diffusivity, apparent diffusion coefficient, and fraction anisotropy in different regions of the brain and correlation with symptom severity. Acad Radiol 14: 839–846, 2007.
  • Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ: Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome: A study with single-voxel magnetic resonance spectroscopy. J Rheumatol 35: 1371–1377, 2008.
  • Wood PB, Ledbetter CR, Glabus MF, Broadwell LK, Patterson JC 2nd: Hippocampal metabolite abnormalities in fibromyalgia: Correlation with clinical features. J Pain 10: 47–52, 2009.
  • Harris RE, Sundgren PC, Pang Y, Hsu M, Petrou M, Kim SH, McLean SA, Gracely RH, Clauw DJ: Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 58: 903–907, 2008.
  • Harris RE, Sundgren PC, Craig AD, Kirshenbaum E, Sen A, Napadow V, Clauw DJ: Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 60: 3146–3152, 2009.
  • Gracely RH, Petzke F, Wolf JM, Clauw DJ: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46: 1333–1343, 2002.
  • Pujol J, López-Solà M, Ortiz H, Vilanova JC, Harrison BJ, Yücel M, Soriano-Mas C, Cardoner N, Deus J: Mapping brain response to pain in fibromyalgia patients using temporal analysis of FMRI. PLoS One 4: e5224, 2009.
  • Jensen KB, Kosek E, Petzke F, Carville S, Fransson P, Marcus H, Williams SC, Choy E, Giesecke T, Mainguy Y, Gracely R, Ingvar M: Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain 144: 95–100, 2009.
  • Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH: Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 31: 364–378, 2004.
  • Staud R, Craggs JG, Perlstein WM, Robinson ME, Price DD: Brain activity associated with slow temporal summation of C-fiber evoked pain in fibromyalgia patients and healthy controls. Eur J Pain 12: 1078–1089, 2008.
  • Burgmer M, Pogatzki-Zahn E, Gaubitz M, Wessoleck E, Heuft G, Pfleiderer B: Altered brain activity during pain processing in fibromyalgia. Neuroimage 44: 502–508, 2009.
  • Giesecke T, Gracely RH, Williams DA, Geisser ME, Petzke FW, Clauw DJ: The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 52: 1577–1584, 2005.
  • Gracely RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA, Clauw DJ: Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 127: 835–843, 2004.
  • Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA, Bushnell MC, Chizh BA: Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25: 3576–3582, 2007.
  • Grace AA, Floresco SB, Goto Y, Lodge DJ: Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30: 220–227, 2007.
  • Bangert AS, Glass JM, Welsh RC, Crofford LJ, Taylor SF, Park DC: Functional magnetic resonance imaging of working memory in fibromyalgia [abstract]. Arthritis Rheum 48: S90, 2003.
  • McEwen BS: Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol Rev 87: 873–904, 2007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.